Literature DB >> 19409554

The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome.

Sarantis Livadas1, Georgios Boutzios, Fragiskos Economou, Krystallenia Alexandraki, Xenofon Xyrafis, Maria Christou, Aristea Zerva, Athanasios Karachalios, Evangelia Tantalaki, Evanthia Diamanti-Kandarakis.   

Abstract

OBJECTIVE: To investigate the effects of oral natural micronized P on hormonal and metabolic parameters in patients with polycystic ovary syndrome (PCOS) and to answer the clinical question whether induction of withdrawal bleeding is a necessity for the comparison of hormonal and metabolic data in subjects with PCOS.
DESIGN: Prospective clinical study.
SETTING: Academic medical center. PATIENT(S): Twenty-eight reproductive-aged women with PCOS. MAIN OUTCOME MEASURE(S): Blood sampling was collected at baseline, after 7 days of oral natural micronized P (200 mg) administration, and after withdrawal bleeding. At these three stages hormonal parameters and homeostasis assessment model (HOMA-IR) index were assessed in all patients. RESULT(S): Oral natural micronized P administration did not alter significantly insulin sensitivity index and androgen levels; however, LH was decreased when postbleeding values were compared to baseline. Nevertheless, after oral natural micronized P administration, P and 17alpha-hydroxyprogesterone (17-OHP) concentrations were increased, and HOMA-IR was decreased, whereas androgens levels were not altered, in comparison with baseline. CONCLUSION(S): The induction of withdrawal bleeding, with this regimen, does not appear to be a necessity for the assessment of hormonal and metabolic profile in anovulatory women with PCOS. Crown Copyright (c) 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409554     DOI: 10.1016/j.fertnstert.2009.02.073

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.

Authors:  Miro Šimun Alebić; Tomislav Bulum; Nataša Stojanović; Lea Duvnjak
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

2.  An Update on Contraception in Polycystic Ovary Syndrome.

Authors:  Seda Hanife Oguz; Bulent Okan Yildiz
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.